Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma
Open Access
- 10 July 2017
- journal article
- research article
- Published by IOS Press in Tumor Biology
- Vol. 39 (7)
- https://doi.org/10.1177/1010428317701653
Abstract
Human renal cell carcinoma which is a highly vascular tumor is the leading cause of death from urologic cancers. Angiogenesis has a pivotal role in oncogenesis and in the viability and expansion of renal cell carcinoma. Rap2B, as a small guanosine triphosphate–binding protein of the Ras family, was first discovered in the early 1990s during the screening of a platelet complementary DNA library. Previous studies have shown that Rap2B aberrantly expressed in human carcinogenesis and promoted the development of tumors via multiple signaling pathways. However, the function of Rap2B in tumor angiogenesis that is necessary for tumor growth and metastasis remains unknown. In this study, we examined the role of Rap2B in angiogenesis in renal cell carcinoma by Western blot, quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, human umbilical vascular endothelial cells growth assay, and endothelial cell tube formation assay. We found that Rap2B promoted angiogenesis in vitro and in vivo. Moreover, our data illustrated that phosphoinositide 3-kinase/AKT signaling pathway is involved in Rap2B-mediated upregulation of vascular endothelial growth factor and renal cell carcinoma angiogenesis. Taken together, these results revealed that Rap2B promotes renal cell carcinoma angiogenesis via phosphoinositide 3-kinase/AKT/vascular endothelial growth factor signaling pathway, which suggests that Rap2B is a novel therapeutic target for renal cell carcinoma anti-angiogenesis therapy.This publication has 42 references indexed in Scilit:
- Biological characteristics of Rh123high stem-like cells in a side population of 786-O renal carcinoma cellsOncology Letters, 2013
- RUNX3 Suppresses Migration, Invasion and Angiogenesis of Human Renal Cell CarcinomaPLOS ONE, 2013
- Cancer prevention by targeting angiogenesisNature Reviews Clinical Oncology, 2012
- Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ3Blood, 2011
- The changing pattern of kidney cancer incidence and mortality in EuropeBJU International, 2008
- Molecular regulation of angiogenesis and lymphangiogenesisNature Reviews Molecular Cell Biology, 2007
- Rap1 Integrates Tissue Polarity, Lumen Formation, and Tumorigenic Potential in Human Breast Epithelial CellsCancer Research, 2007
- Rap1: a key regulator in cell-cell junction formationJournal of Cell Science, 2007
- Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridizationCancer Letters, 2004
- Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesisInternational Journal of Cancer, 2002